Neutrophils are important in the host response against invading pathogens. One chemical defense mechanism employed by neutrophils involves the production of myeloperoxidase (MPO)-derived HOCl. 2-Chlorohexadecanal (2-ClHDA) is a naturallyoccurring lipid product of HOCl targeting the vinyl ether bond of plasmalogens. Previous studies have shown that exogenously-added 2-ClHDA is oxidized to 2-chlorohexadecanoic acid (2-ClHA) and reduced to 2-chlorohexadecanol (2-ClHOH) by endothelial cells. These studies show that both 2-ClHA and 2-ClHOH are produced in activated neutrophils in an MPO-and time-dependent manner, and are released by neutrophils into media. 2-ClHDA levels peak following 30 min of PMA stimulation. In contrast, 2-ClHA and 2-ClHOH levels steadily increased over 60 minutes, suggesting a precursor-product relationship between 2-ClHDA and both 2-ClHA and 2-ClHOH.
Introduction
Neutrophils are the most abundant of the innate immune system's cellular arsenal that combats invading pathogens (1-3). Upon activation, neutrophils undergo a respiratory burst leading to the production and release of hydrogen peroxide (H 2 O 2 ) and concomitant release of myeloperoxidase (MPO) from the azurophilic granules. MPO amplifies the oxidant response of neutrophils by converting hydrogen peroxide to hypochlorous acid (4, 5) . Hypochlorous acid is in equilibrium with chlorine gas (4).
Collectively, hypochlorous acid, its conjugate anion, hypochlorite, and chlorine gas comprise the reactive chlorinating species (RCS) produced by activated neutrophils. In addition to targeting invading organisms, these RCS also attack host macromolecules including proteins, nucleic acids, and lipids (1, [6] [7] [8] [9] [10] [11] [12] [13] . RCS attack of the vinyl ether bond of plasmalogens results in the release of α-chlorofatty aldehyde (α-ClFALD) and unsaturated lysophosphatidylcholine production (14) . One of the α-ClFALD molecular species, 2-chlorohexadecanal (2-ClHDA), is produced by activated neutrophils and monocytes and has been shown to accumulate in infarcted myocardium (8) and human atheromas (15) . Since neutrophil derived 2-ClHDA levels peak within the first 30 minutes of stimulation by phorbol ester (18), it is likely that decreasing levels of 2-ClHDA following 30 minutes of phorbol ester stimulation is due to reduced 2-ClHDA production under conditions that 2-ClHDA is metabolized. Accordingly, it is predicted that stable 2-ClHDA metabolites may be detected in vivo under pro-inflammatory conditions. In the present study both 2-ClHA and 2-ClHOH are shown to accumulate in activated human neutrophils following peak accumulation of 2-ClHDA. Furthermore, 2-ClHA is found in both the plasma and bronchoalveolar lavage of mice infected intranasally with Sendai virus (SeV). Additional studies support a role for the enzymatic pathways of the fatty alcohol cycle for the production of these additional members of a chlorinated lipidome that is produced by the initial targeting of plasmalogens by RCS. Samples used to quantify 2-ClHOH were derivatized with 2,3,4,5,6-pentafluorobenzoyl (PFB) chloride, forming PFB esters, which were analyzed by GC-MS using selected ion monitoring (SIM) as previously described (16) . Lastly, samples containing 2-ClHA were analyzed by LC-ESI/MS as previously described (16) , except that a Supelco Discovery ® HS 18 column was employed.
Materials and Methods

Synthesis
Neutrophil Activation and Chemotaxis. As previously described (18), whole blood (50 ml) was taken from healthy volunteers and anticoagulated with EDTA (final concentration 5.4 mM) prior to the isolation of neutrophils using a Ficoll-Hypaque gradient as previously described (22). These studies were approved and authorized by the Total lung RNA was isolated using the RNeasy® Mini Kit (Qiagen). For these studies, lungs were snap frozen and pulverized at the temperature of liquid nitrogen in preparation for the isolation of RNA. cDNA was synthesized using the iScript™ cDNA Synthesis Kit (Bio-Rad) followed by real-time (RT) PCR using iQ™ SYBR® Green
Supermix to amplify SeV-specific RNA (accession number X58886), forward primer nt 3909-3928, reverse primer nt 4049-4068; and published mouse 36B4 primers (25) .
Products of RT-PCR were run out on a 1% agarose gel to confirm product size of the amplicon and to quantify levels of SeV amplicon normalized to 36B4 using ImageJ software.
Lung MPO activity was measured from whole lung tissue homogenates as previously described (26) and normalized to tissue dry weight. One unit of MPO activity was defined as that degrading one micromole H 2 O 2 in 1 min at 25°C.
Statistical analysis.
Statistical analysis was performed between multiple groups using ANOVA. Experiments containing only two groups were subjected to a two-tailed student's t-test. Based on these data showing differences in cell-associated 2-ClHA and 2-ClHOH in comparison to the levels in the cell culture media additional studies were performed on activated neutrophils to delineate the relative amounts of chlorinated lipid species associated with the activated neutrophil as compared to that released from the neutrophils. The levels of 2-ClHA released into the media under these conditions were less than those which were cell associated (approximately sevenfold difference between cells and media after 60 minutes of PMA stimulation); however, the levels of 2-ClHOH released into the media were similar to the cell associated levels (Figs. 5A and 5B). In contrast to the CHO.K1 and FAA.K1A cells, activated neutrophils preferentially accumulate greater levels of 2-ClHA ( Fig 5A) than 2-ClHOH (Fig 5B) . 11 (27, 28) , including 2-ClHDA, are neutrophil chemoattractants (18). This study found that low to high nanomolar concentrations of 2-ClHA and 2-ClHOH are not chemoattractants (Fig 6) . Furthermore, when added to fMLP, a known neutrophil chemoattractant, 2-ClHA decreased net neutrophil migration (Fig 6A) similar to 2-ClHOH (Fig 6B) .
Results
Endogenous production of 2-ClHA and 2-ClHOH in phorbol ester
Production of 2-ClHA in an animal model of a lower respiratory tract infection. In order to determine if chlorinated lipid species are produced in vivo, we utilized a mouse model of respiratory viral infection. Sendai virus is a natural mouse pathogen that causes a neutrophilic bronchiolitis. During SeV infection, neutrophil infiltration in the lung peaks on day 3 postinfection, prior to the peak of both macrophage and lymphocyte influx (24). Therefore, experiments were terminated on day 3 when both BALF and serum were collected. Neutrophil activation in the lungs on day 3 was confirmed by increased myeloperoxidase activity in the lungs of infected lungs compared to controls (Fig 7D) . Real-time PCR for SeV transcript was used to confirm the presence of virus in the lungs of infected mice; no viral transcript was detected in the uninfected controls (Fig 7C) . BALF from infected mice contained approximately three-fold greater quantities of 2-ClHA than control uninfected mice (Fig 7A) . In addition to the localized 2-ClHA in the lungs, systemic 2-ClHA levels were increased. Plasma from infected mice had a greater abundance of 2-ClHA than in control counterparts (Fig 7B) . Neither 2-ClHDA nor 2-ClHOH were detected in BALF or in plasma from control and SeV infected mice.
Taken together, this provides evidence that 2-ClHA can be measured systemically, in addition to specific sites of inflammation and these data suggest that 2-ClHA is a stable metabolite produced as a result of RCS attack of plasmalogens in vivo. It has been previously shown that neutrophils infiltrate the lungs of SeV-infected mice.
Neutrophils are the predominant cell present in the BALF until day 5, when macrophages and lymphocytes increase in number (24). The involvement of neutrophil activation and MPO-derived products in this model was verified by showing that 2-ClHA accumulated in BALF collected from SeV-infected mice compared to control-treated mice. Moreover, 2-ClHA, which we assume is locally produced at the site of infection in the lung, is also increased in the plasma of these mice. The finding that only 2-ClHA is present suggests that activated neutrophils rapidly convert 2-ClHDA to 2-ClHA and release this lipid. This is supported by our findings using human neutrophils which show that 2-ClHDA levels peak 30 minutes after activation and then decrease due to metabolism to 2-ClHA and 2-ClHOH. The absence of 2-ClHOH in BALF and plasma suggests that 2-ClHA is the by guest, on October 30, 2017 www.jlr.org Downloaded from preferential metabolite that is released from neutrophils in comparison to 2-ClHOH. It is assumed that intracellular 2-ClHOH may be oxidized to 2-ClHA. Additionally, it should be appreciated that plasma fatty acid levels are at least 2-3 orders of magnitude greater than that of plasma fatty alcohol levels (e.g., plasma palmitoyl alcohol levels have been shown to be ~200 nM (38)). Taken together, these data suggest that plasma levels of the 2-ClHDA oxidation product, 2-ClHA, may serve as a stable biomarker of inflammation.
Taken together, the present study demonstrates a new group of chlorinated lipids that are produced by activated neutrophils. These lipids are also produced in vivo at sites of inflammation as well as increased in the circulation of mice with a respiratory infection. Although these studies focus on the role of neutrophils in the accumulation of these chlorinated lipid species it is likely that they are also produced by activated monocytes and MPO-containing macrophages. 
